Truist Financial
IHE icon

Truist Financial’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Truist Financial’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$962K Buy
9,721
+701
+8% +$63.2K ﹤0.01% 1800
2026
Q1 		$782K Buy
9,020
+407
+5% +$35.6K ﹤0.01% 1839
2025
Q4 		$731K Sell
8,613
-251
-3% -$20K ﹤0.01% 1833
2025
Q3 		$643K Sell
8,864
-240
-3% -$16.6K ﹤0.01% 1878
2025
Q2 		$593K Buy
9,104
+252
+3% +$16.4K ﹤0.01% 1874
2025
Q1 		$625K Sell
8,852
-2,394
-21% -$166K ﹤0.01% 1748
2024
Q4 		$739K Buy
11,246
+3,576
+47% +$246K ﹤0.01% 1691
2024
Q3 		$542K Buy
7,670
+1,355
+21% +$94.4K ﹤0.01% 1815
2024
Q2 		$419K Sell
6,315
-989
-14% -$64.8K ﹤0.01% 2081
2024
Q1 		$496K Sell
7,304
-6,805
-48% -$450K ﹤0.01% 1971
2023
Q4 		$872K Buy
14,109
+159
+1% +$9.35K ﹤0.01% 1668
2023
Q3 		$823K Sell
13,950
-231
-2% -$14.2K ﹤0.01% 1650
2023
Q2 		$847K Sell
14,181
-1,128
-7% -$67.1K ﹤0.01% 1666
2023
Q1 		$895K Buy
15,309
+5,139
+51% +$310K ﹤0.01% 1618
2022
Q4 		$631K Buy
10,170
+6
+0.1% +$361 ﹤0.01% 1797
2022
Q3 		$575K Buy
10,164
+306
+3% +$18.8K ﹤0.01% 1750
2022
Q2 		$630K Buy
9,858
+468
+5% +$29.7K ﹤0.01% 1768
2022
Q1 		$608K Sell
9,390
-81
-0.9% -$5.13K ﹤0.01% 1885
2021
Q4 		$631K Sell
9,471
-9,654
-50% -$612K ﹤0.01% 1892
2021
Q3 		$1.17M Buy
19,125
+879
+5% +$55.9K ﹤0.01% 1516
2021
Q2 		$1.13M Sell
18,246
-3,345
-15% -$203K ﹤0.01% 1566
2021
Q1 		$1.28M Sell
21,591
-105
-0.5% -$6.33K ﹤0.01% 1446
2020
Q4 		$1.3M Buy
21,696
+2,478
+13% +$141K ﹤0.01% 1356
2020
Q3 		$1.05M Buy
19,218
+4,137
+27% +$223K ﹤0.01% 1348
2020
Q2 		$773K Sell
15,081
-768
-5% -$38.6K ﹤0.01% 1407
2020
Q1 		$711K Buy
15,849
+822
+5% +$41.5K ﹤0.01% 1399
2019
Q4 		$802K Buy
+15,027
New +$741K ﹤0.01% 1558

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Truist Financial's IHE Position: Q2 2026 in Review

Truist Financial increased its iShares US Pharmaceuticals ETF (IHE) stake by 7.8% in Q2 2026, buying an estimated $63.2K and bringing the position to 9,721 shares worth $962K. The position accounts for ﹤0.01% of the portfolio, ranked #1800.

Truist Financial first reported a position in IHE in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.3M in Q4 2020. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Truist Financial held 9,721 shares of iShares US Pharmaceuticals ETF worth $962K as of Q2 2026.
  • Truist Financial bought 701 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $63.2K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #1800 holding.
  • Truist Financial first reported a position in iShares US Pharmaceuticals ETF in Q4 2019 and has held it in 27 quarters since.
  • Truist Financial's iShares US Pharmaceuticals ETF position peaked at $1.3M in Q4 2020.
  • 210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.